• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型(非胰岛素依赖型)糖尿病动脉风险评估与管理策略。欧洲动脉风险政策小组代表国际糖尿病联盟欧洲区域。

A strategy for arterial risk assessment and management in type 2 (non-insulin-dependent) diabetes mellitus. European Arterial Risk Policy Group on behalf of the International Diabetes Federation European Region.

出版信息

Diabet Med. 1997 Jul;14(7):611-21. doi: 10.1002/(SICI)1096-9136(199707)14:7<611::AID-DIA422>3.0.CO;2-9.

DOI:10.1002/(SICI)1096-9136(199707)14:7<611::AID-DIA422>3.0.CO;2-9
PMID:9223402
Abstract

People with Type 2 (non-insulin-dependent) diabetes mellitus die mainly from cardiovascular and cerebrovascular disease. Furthermore, the major burden of their symptoms arise from arterial disease, including peripheral vascular disease. However, management guidelines for Type 2 diabetes continue to focus on blood glucose control, which is only one of a number of arterial risk factors found with this type of diabetes. Clinically it is evident that blood glucose control continues to occupy centre-stage in the management of Type 2 diabetes as practised by many physicians. Even when arterial risk factors such as smoking or raised serum triglycerides are noted, their management is often relatively neglected. As part of the St Vincent Declaration Action Programme, a working group has sought consensus on the number and relative importance of arterial risk factors requiring management in quality diabetes care. The group seeks to assist those devising protocols and guidelines, records and quality systems, and those charged with directly advising and educating people with diabetes. Arterial risk factors that can be routinely identified and monitored, and modified by application of management protocols, include high blood pressure, high serum total and LDL cholesterol, low serum HDL cholesterol and raised serum triglycerides, poor blood glucose control, smoking, high body mass index and body fat distribution. Aspirin can modify hypercoagulability, but this is not easily monitored. Arterial risk factors that cannot be modified, but which have an impact on the intensity of management of other factors, include ethnic group, gender, and family history of arterial disease. Raised albumin excretion is an arterial risk factor and can be modified, but it is not clear whether this reduces cardiovascular risk. For many of the risk factors, levels of high, medium, and low risk can be set. These can be used, in consultation with the patient, to determine appropriate interventions and provide feedback on risk reduction resulting from successful management.

摘要

2型(非胰岛素依赖型)糖尿病患者主要死于心血管和脑血管疾病。此外,他们症状的主要负担源于动脉疾病,包括外周血管疾病。然而,2型糖尿病的管理指南仍继续侧重于血糖控制,而血糖控制只是这类糖尿病所发现的众多动脉危险因素之一。临床上很明显,血糖控制在许多医生对2型糖尿病的管理中仍然占据核心地位。即使注意到吸烟或血清甘油三酯升高等动脉危险因素,其管理往往也相对被忽视。作为《圣文森特宣言行动计划》的一部分,一个工作组已就优质糖尿病护理中需要管理的动脉危险因素的数量和相对重要性达成共识。该小组旨在协助那些制定方案和指南、记录和质量体系的人员,以及那些负责直接为糖尿病患者提供建议和教育的人员。可以通过应用管理方案进行常规识别、监测和改变的动脉危险因素包括高血压、血清总胆固醇和低密度脂蛋白胆固醇升高、血清高密度脂蛋白胆固醇降低、血清甘油三酯升高、血糖控制不佳、吸烟、高体重指数和体脂分布。阿司匹林可以改变血液高凝状态,但这不易监测。无法改变但会影响其他因素管理强度的动脉危险因素包括种族、性别和动脉疾病家族史。白蛋白排泄增加是一种动脉危险因素且可以改变,但尚不清楚这是否能降低心血管风险。对于许多危险因素,可以设定高、中、低风险水平。这些水平可与患者协商后用于确定适当的干预措施,并就成功管理导致的风险降低情况提供反馈。

相似文献

1
A strategy for arterial risk assessment and management in type 2 (non-insulin-dependent) diabetes mellitus. European Arterial Risk Policy Group on behalf of the International Diabetes Federation European Region.2型(非胰岛素依赖型)糖尿病动脉风险评估与管理策略。欧洲动脉风险政策小组代表国际糖尿病联盟欧洲区域。
Diabet Med. 1997 Jul;14(7):611-21. doi: 10.1002/(SICI)1096-9136(199707)14:7<611::AID-DIA422>3.0.CO;2-9.
2
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
3
[Cardiovascular risk factors and prevention in women: similarities and differences].[女性心血管危险因素与预防:异同]
Ital Heart J Suppl. 2001 Feb;2(2):125-41.
4
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.口服避孕甾体激素对动脉血栓形成生化标志物的药效学作用。非糖尿病女性和胰岛素依赖型糖尿病女性的研究。
Dan Med Bull. 2002 Feb;49(1):43-60.
5
Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.2型糖尿病患者群体中总同型半胱氨酸水平与糖尿病慢性并发症、身体成分及其他心血管危险因素的关系
J Diabetes Complications. 2005 Jan-Feb;19(1):42-6. doi: 10.1016/j.jdiacomp.2003.12.003.
6
[Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].[2000年西班牙的胆固醇血症控制。心血管疾病预防工具。卫生与消费部、西班牙心脏病学会和西班牙动脉硬化学会]
Rev Esp Salud Publica. 2000 May-Jun;74(3):215-53.
7
Diet and lifestyle guidelines and desirable levels of risk factors for the prevention of diabetes and its vascular complications in Indians: a scientific statement of The International College of Nutrition. Indian Consensus Group for the Prevention of Diabetes.预防印度人群糖尿病及其血管并发症的饮食和生活方式指南以及危险因素的理想水平:国际营养学院科学声明。印度糖尿病预防共识小组
J Cardiovasc Risk. 1997 Jun;4(3):201-8.
8
[Tuberculosis in compromised hosts].[免疫功能低下宿主中的结核病]
Kekkaku. 2003 Nov;78(11):717-22.
9
Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.新西兰2型糖尿病患者三种不同心血管疾病风险评估方法的比较。
N Z Med J. 2008 Sep 5;121(1281):49-57.
10
Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective.家族病史是检测有患糖尿病和心血管疾病风险儿童的有用工具吗?从公共卫生角度来看。
Pediatrics. 2007 Sep;120 Suppl 2:S78-86. doi: 10.1542/peds.2007-1010G.

引用本文的文献

1
Risk vs benefit in diabetes pharmacotherapy: a rational approach to choosing pharmacotherapy in type 2 diabetes.糖尿病药物治疗的风险与获益:2 型糖尿病药物治疗选择的合理方法。
Curr Diab Rep. 2013 Jun;13(3):319-28. doi: 10.1007/s11892-013-0374-z.
2
Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials.2型糖尿病与心血管风险的管理:干预试验的经验教训
Drugs. 2000 Nov;60(5):975-83. doi: 10.2165/00003495-200060050-00001.
3
Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
2型糖尿病患者从口服药物转换为胰岛素治疗的益处与风险
Drug Saf. 1999 Jul;21(1):7-22. doi: 10.2165/00002018-199921010-00002.